Search

everythinglearnresearchcommunity

for

Search:↓

The document says that Androgenetic alopecia, a common hair loss condition, affects women less often and usually less severely, but early diagnosis and treatment are important.

Androgenetic alopecia, or hair loss, is influenced by hormones and genetics, and can be treated with medications like minoxidil, finasteride, or hormone therapy, with effectiveness evaluated after 6 months.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

The environment around the time of conception can change the VTRNA2-1 gene in a way that lasts for years and may affect disease risk.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Quercetin effectively treated and prevented hair loss in mice.

COVID-19 infection can significantly cause temporary hair loss.

Researchers found WNT10A to be a key gene in developing goat hair follicles.

Epidermal stem cells create and maintain skin structures like hair and nails through specific signaling pathways and vary by location and function.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

Reflectance confocal microscopy reliably identifies skin cancer features like horizontal skin tissue sections.

Using hair follicles can improve skin drug delivery.

Your skin is like an ecosystem, with its own community of microbes and substances that interact and affect its health.

GLPLS is a rare skin condition with specific hair loss and skin symptoms.

Special particles from umbilical cord stem cells help heal skin wounds in diabetic mice by preventing certain immune cell death.

1 mg/day oral finasteride significantly improves hair growth in men with male pattern baldness.

Menstrual abnormalities in PCOS women may not greatly affect their metabolic and hormonal profile.

Human hair loss may have evolved to help increase brain size.

Autism's genetics are linked with early age of puberty and less hair loss, but not with hormone levels or polycystic ovary syndrome.

Dutasteride and finasteride cause kidney damage, with dutasteride being more harmful.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Hormone testing may not be very helpful in diagnosing female pattern hair loss.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

The document's conclusion cannot be provided because the content is not available to parse.

Arsenic exposure from contaminated water severely damages the skin, causing hair loss, pigmentation changes, irritation, and can lead to skin cancer.

PRP with finasteride is better for hair regrowth than minoxidil with finasteride.